Kugaevskaia E V, Pavlikhina L V, Eliseeva Iu E
Vopr Med Khim. 1994 May-Jun;40(3):9-11.
A high molecular form of angiotensin-converting enzyme with mol mass about 600 kDa was found simultaneously with the well-known low molecular enzyme form of 190 kDa after fractionation of freshly prepared extracts from bovine kidney cortex and lung tissues by means of ammonium sulfate or gel filtration on Sephadex G-200. The rate of substrate hydrolysis was adequately Cl'-dependent for both these enzyme forms and specific inhibitors nonapeptide SQ 20881 and pentapeptide SQ 20475 inhibited similarly their activity. The enzyme high molecular form transformed into its low molecular derivative after storage, in freezing-thawing and ultrafiltration. Aprotinin, the inhibitor of serine proteinases, inhibited this kind of transformation. Stable form of the high molecular angiotensin-converting enzyme, which did not transform into its low molecular derivative, was obtained after treatment with agarose-immobilized aprotinin. Endogenous serine proteinases, which may regulate the angiotensin-converting activity in vivo, appears to be responsible for the enzyme transformation into its low molecular derivative.
在用硫酸铵分级分离或通过Sephadex G - 200凝胶过滤对新鲜制备的牛肾皮质和肺组织提取物进行分级分离后,发现了一种分子量约为600 kDa的高分子形式的血管紧张素转换酶,同时还发现了众所周知的分子量为190 kDa的低分子酶形式。这两种酶形式的底物水解速率都充分依赖于Cl⁻,并且特异性抑制剂九肽SQ 20881和五肽SQ 20475对它们活性的抑制作用相似。高分子形式的酶在储存、冻融和超滤后会转化为其低分子衍生物。丝氨酸蛋白酶抑制剂抑肽酶抑制了这种转化。用琼脂糖固定的抑肽酶处理后,获得了不会转化为低分子衍生物的高分子血管紧张素转换酶的稳定形式。内源性丝氨酸蛋白酶可能在体内调节血管紧张素转换活性,似乎是该酶转化为低分子衍生物的原因。